CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population. (Q46126673)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Cinzia Ciccacci

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Vittorio Forte

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Elisabetta Sirianni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Lucia Novelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Placido Bramanti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Giuseppe Novelli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

261-266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

Prospects and limits of pharmacogenetics: the thiopurine methyl transferase (TPMT) experience

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

Genetic determinants of response to warfarin during initial anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

CYP4F2 genetic variant alters required warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.2.261

10.2217/14622416.10.2.261

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19207028%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference